Table 1.
Women from Brazil | ||||
| ||||
Pathology | Case patients. | Age | Brn-3a mRNA | HPV E6 mRNA |
No. (%) | Mean | Mean | Mean | |
| ||||
Cervicitis | 32 (38.5) | 39.4 | 0.2a∗ | 0.17⋀b |
SCC precancer | 32 (38.5) | 50.7 | 0.58* | 0.55⋀ |
*P = .000001 | P = .000002 | |||
AC precancer | 17 (20.5) | 44 | 0.47a | 0.4b |
a P = .00033 | b P = .001 | |||
SSCC | 2 (2.5) | 35 | <0.1† | <0.1† |
†0< negligible < 0.1 | †0< negligible < 0.1 | |||
| ||||
Women from England | ||||
| ||||
Pathology | Case patients. | Age | Brn-3a mRNA | HPV E6 mRNA |
No (%) | Mean | Mean | Mean | |
| ||||
Cervicitis | 32 (60.4) | 37.2 | 0.21* | 0.17⋀ |
SCC precancer | 17 (32.1) | 28.8 | 0.46* | 0.30⋀ |
*P = .0003 | ⋀ P = .01 | |||
AC precancer | 4 (7.5) | 38.5 | 0.46 | 0.41 |
SSCC | 0 | — | — | — |
| ||||
Total women in study | ||||
| ||||
Pathology | Total case patients. | Age | Brn-3a mRNA | HPV E6 mRNA |
No (%) | Mean | Mean | Mean | |
| ||||
Cervicitis | 32 + 32 (47.1) | 38.3 | 0.20∗a | 0.17⋀ |
SCC precancer | 32 + 17 (36) | 39.8 | 0.52* | 0.42⋀ |
*P = .000052 | ⋀ P = .00046 | |||
AC precancer | 17 + 4 (15.4) | 41.1 | 0.46a | 0.42b |
a P = .000026 | b P = .0001 | |||
SSCC | 2 + 0 (1.5) | 35 | <0.1† | <0.1† |
†0< negligible < 0.1 | †0< negligible < 0.1 |